Retrospective analysis of pts treated at 2 cancer centers in the United States and Greece; 100 pts received a variety of chemotherapy regimen that included cetuximab.Primary or secondary endpoints were not defined.Sequence variants in KRAS and BRAF were identified using PCR followed by mass-spectrometric genotyping or Sanger sequencing. This evidence concerns the gene BRAF and cancer.